New Approach May Counter Autoimmunity
NYU Langone researchers found in a new study in mice that an engineered protein turns off the immune cells most likely to damage tissue in several conditions.
New Approach Promises to Revolutionize MRI Scanner Design
NYU Langone researchers harness imperfections that typically compromise MRI exams to achieve superior images.
New Approach to Treating Osteoarthritis Advances
NYU Langone study in rodents shows that injections of a natural “energy” molecule prompted regrowth of cartilage lost with aging in knees.
New Beta Thalassemia Treatment May Reduce Blood Transfusions
Dr. Jun H. Choi, a hematologist–oncologist at NYU Langone’s Perlmutter Cancer Center, discusses a new treatment for beta thalassemia.
New Biologic Could Target Cancer-Causing Proteins
NYU Langone study describes the development of a biologic drug that targets a mutant cancer protein, HER2, without attacking its counterpart on healthy cells.
New Biotech ‘Incubator’ Coming to Manhattan
NYU Langone’s new biotech “incubator” will house up to 35 startup companies seeking to turn discoveries into profitable businesses.
New Blood Tests for Detecting Skin Cancers
NYU Langone study shows two new blood tests can reliably detect previously unidentifiable forms of skin cancer.
New Center & Genetic Research Take Aim at Lung Cancer
NYU Langone launches its Lung Cancer Center and researchers discover a new therapeutic vulnerability for non-small cell lung cancer.
New Center Offers Primary & Acute Care for Men
Routine acute care and long-term prevention of diseases that affect men are the focus of the new Preston Robert Tisch Center for Men’s Health.
New Center Tackles Myths About Fibroids
NYU Langone launches a center dedicated to offering women a broad range of treatment options to meet their individual needs for fibroid care.